Foryouvape Report, December 16 news, according to foreign news reports, according to Nielsen’s analysis of convenience store data, in the four weeks ending December 4, Juul’s market share was 38.2%, lower than the previous 38.8% of the report. Vuse e-cigarettes remain stable with a 34% market share, only 4.2% behind Juul e-cigarettes.
According to reports, NJoy is 3%, which is the same as the previous report, while Fontem Ventures’ blu eCigs is 2.4%, which is also unchanged. Overall, driven by recent price increases, e-cigarette sales have increased by 6.7% year-on-year in the last four weeks.
Juul’s 4-week sales have fallen from a 50.2% increase on August 10, 2019 to a 9.7% drop in the latest report. In contrast, Renault’s Vuse rose 50.1% in the latest report, while the third-ranked NJoy fell 23.2%, and the fourth-ranked blue eCigs fell 13.8%.
Goldman Sachs analyst Bonnie Herzog once said that NJoy refuted Nielsen’s data and methodology.
On October 12, the FDA issued a landmark ruling, approving Vuse Solo products from a public health perspective as suitable for sale to smokers. The FDA order covers the tobacco flavor of the Vuse Solo closed electronic nicotine delivery system, its power unit and two replacement cartridges.
However, the FDA rejected the submission of 10 flavored Vuse Solo products. It stated that it is still evaluating the company’s application for mint-flavored products for Vuse Solo.
Renault stated that the FDA’s order confirms that Vuse Solo products are suitable for protecting public health, emphasizing that years of scientific research and research are committed to ensuring that adult nicotine consumers over 21 can obtain innovative, potentially less harmful, traditional nicotine substitutes.
